These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2361659)

  • 1. White matter changes in dementia of Alzheimer's type: the difference in vulnerability between cell compartments.
    Englund E; Brun A
    Histopathology; 1990 May; 16(5):433-9. PubMed ID: 2361659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. White matter changes in dementia of Alzheimer's type. Biochemical and neuropathological correlates.
    Englund E; Brun A; Alling C
    Brain; 1988 Dec; 111 ( Pt 6)():1425-39. PubMed ID: 3208064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study.
    Brun A; Englund E
    Ann Neurol; 1986 Mar; 19(3):253-62. PubMed ID: 3963770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arteriolosclerotic leucoencephalopathy in the elderly and its relation to white matter lesions in Binswanger's disease, multi-infarct encephalopathy and Alzheimer's disease.
    Ferrer I; Bella R; Serrano MT; Martí E; Guionnet N
    J Neurol Sci; 1990 Aug; 98(1):37-50. PubMed ID: 2230830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreasing myelin density reflected increasing white matter pathology in Alzheimer's disease--a neuropathological study.
    Sjöbeck M; Haglund M; Englund E
    Int J Geriatr Psychiatry; 2005 Oct; 20(10):919-26. PubMed ID: 16163742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the apolipoprotein E epsilon4 allele on white matter hyperintensities in dementia.
    Hirono N; Yasuda M; Tanimukai S; Kitagaki H; Mori E
    Stroke; 2000 Jun; 31(6):1263-8. PubMed ID: 10835442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology of white matter perfusion in Alzheimer's disease and vascular dementia.
    Barker R; Ashby EL; Wellington D; Barrow VM; Palmer JC; Kehoe PG; Esiri MM; Love S
    Brain; 2014 May; 137(Pt 5):1524-32. PubMed ID: 24618270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffuse vacuolization (spongiosis) and arteriolosclerosis in the frontal white matter occurs in vascular dementia.
    Erkinjuntti T; Benavente O; Eliasziw M; Munoz DG; Sulkava R; Haltia M; Hachinski V
    Arch Neurol; 1996 Apr; 53(4):325-32. PubMed ID: 8929154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of white matter hyperintensities in Alzheimer's disease: post-mortem quantitative MRI and neuropathology.
    Gouw AA; Seewann A; Vrenken H; van der Flier WM; Rozemuller JM; Barkhof F; Scheltens P; Geurts JJ
    Brain; 2008 Dec; 131(Pt 12):3286-98. PubMed ID: 18927145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurochemical changes in white matter. Aged human brain and Alzheimer's disease.
    Malone MJ; Szoke MC
    Arch Neurol; 1985 Nov; 42(11):1063-6. PubMed ID: 4051835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlations between histopathologic white matter changes and proton MR relaxation times in dementia.
    Englund E; Brun A; Persson B
    Alzheimer Dis Assoc Disord; 1987; 1(3):156-70. PubMed ID: 3453747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased myelin lipids in Alzheimer's disease and vascular dementia.
    Wallin A; Gottfries CG; Karlsson I; Svennerholm L
    Acta Neurol Scand; 1989 Oct; 80(4):319-23. PubMed ID: 2816288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased A beta peptides and reduced cholesterol and myelin proteins characterize white matter degeneration in Alzheimer's disease.
    Roher AE; Weiss N; Kokjohn TA; Kuo YM; Kalback W; Anthony J; Watson D; Luehrs DC; Sue L; Walker D; Emmerling M; Goux W; Beach T
    Biochemistry; 2002 Sep; 41(37):11080-90. PubMed ID: 12220172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral grey and white matter changes in mild cognitive impairment and Alzheimer's disease.
    Luckhaus C
    Eur J Neurol; 2009 Apr; 16(4):438-9. PubMed ID: 19348619
    [No Abstract]   [Full Text] [Related]  

  • 15. Encephalitogenic peptide (EP) in human cerebrovascular white matter lesions.
    Tomimoto H; Akiguchi I; Matsuo A; Terai K; Wakita H; Kimura J; McGeer PL; Budka H
    Neuroreport; 1997 Dec; 8(17):3727-30. PubMed ID: 9427359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cerebral lacunae: still under debate].
    Derouesné C; Poirier J
    Rev Neurol (Paris); 1999 Oct; 155(10):823-31. PubMed ID: 10546297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. White matter changes in Alzheimer's disease: a focus on myelin and oligodendrocytes.
    Nasrabady SE; Rizvi B; Goldman JE; Brickman AM
    Acta Neuropathol Commun; 2018 Mar; 6(1):22. PubMed ID: 29499767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of Alzheimer's disease with extensive focal white matter changes.
    Zahner B; Lang CJ; Engelhardt A; Thierauf P; Neundörfer B
    Dementia; 1995; 6(5):294-300. PubMed ID: 8528377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. White matter lesions, dementia, and ischemic axonopathy.
    Ball MJ
    Alzheimer Dis Assoc Disord; 2003; 17(1):55. PubMed ID: 12621320
    [No Abstract]   [Full Text] [Related]  

  • 20. Which vascular lesions are of importance in vascular dementia?
    Esiri MM
    Ann N Y Acad Sci; 2000 Apr; 903():239-43. PubMed ID: 10818512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.